Stantec heads into its third-quarter report with a story that is mostly working and one piece that still has to prove itself. Margins are at records, backlog keeps climbing and international work is booming, yet the US business, its largest market, stalled last quarter. Management called that pause a matter of project timing rather than weak demand. The September quarter is the first chance to check whether that explanation holds, and it arrives just weeks after Susan Reisbord succeeded Gord Johnston as chief executive on October 1.

The Street is looking for earnings of $1.24 per share, roughly 12% above the year-ago level, on revenue of about $1.30 billion. The consensus revenue figure implies a 16% year-over-year decline. That is hard to square with a record backlog and a reaffirmed full-year outlook, so the top-line comparison should be read with caution, and organic growth rates will say far more about the business. The more telling detail is the full-year picture. Management reaffirmed 2026 earnings guidance of $4.46 to $4.57 per share on revenue of $5.15 billion to $5.30 billion, while consensus sits at $4.43 and $5.12 billion, just below the bottom of both ranges. Analysts are effectively betting that the company lands near or slightly short of its own targets. That gives Stantec a relatively modest bar to clear, provided the second-half acceleration it promised begins to appear.

The US results matter most. American organic growth slid from 4.6% a year earlier to about 2.8% in the first quarter and then to flat in the second, as a Navy program, a western utility job and a southern transit project started slowly. Management trimmed its consolidated organic growth outlook to mid single digits from mid to high single digits, but argued that the US would pick up in the back half and into 2027. Helping that case, the Page acquisition shifts into organic reporting during the second half. A return to positive, low-single-digit US organic growth would support the timing argument. Another flat quarter, especially alongside softer US backlog, would suggest a deeper problem, particularly with the infrastructure law's window for new awards closing in September and surface transportation reauthorization still unresolved.

Margins are the part of the story with the least room for error. Second-quarter adjusted EBITDA margin reached 18.7%, extending a run of roughly seven straight quarters of year-over-year expansion, and management raised its full-year range to 17.8% to 18.3%. With the target already lifted, another record margin is now the expectation rather than a bonus. Backlog, which reached $9.2 billion, should keep rising if global momentum holds. That includes water work growing above 20% and wins such as the Meta data center in Alberta. Cash flow also deserves attention after heavy first-half working capital use pushed days sales outstanding to 75. So does any progress on expanding the share buyback to 5%.

The market has treated Stantec well despite more cautious sentiment. Shares are up 5.6% since the last report while the S&P 500 fell 2.7%, yet sentiment has slipped further into bearish territory. The stock sits right at the top of its post-earnings range near $77.72, testing a breakout, but remains below its 200-day moving average of about $79.51.

In the end, this quarter turns on whether the US slowdown proves temporary. If American organic growth turns positive while margins hold near record levels, the timing explanation gains credibility and the new CEO inherits a clean story. If the US stays stuck, strong international growth and record margins may not be enough to keep the full-year narrative intact.